1 |
Miguel Ricardo Rodríguez Meza, Masanao Nakamura, Takeshi Yamamura, Keiko Maeda, Tsunaki Sawada, Eri Ishikawa, Naomi Kakushima, Kazuhiro Furukawa, Tadashi Iida, Yasuyuki Mizutani, Takuya Ishikawa, Eizaburo Ohno, Takashi Honda, Hiroki Kawashima, Masatoshi Ishigami. Analysis of immunologic comorbidities in ulcerative colitis patients: a tool to prevent exacerbations in ulcerative colitis cases. Nagoya J Med Sci 2022;84. [PMID: 36544593 DOI: 10.18999/nagjms.84.4.733] [Reference Citation Analysis]
|
2 |
Barkhodari A, Lee KE, Shen M, Shen B, Yao Q. Inflammatory bowel disease: focus on enteropathic arthritis and therapy. Rheumatology and Immunology Research 2022;3:69-76. [DOI: 10.2478/rir-2022-0012] [Reference Citation Analysis]
|
3 |
Gomollón F, Seoane-Mato D, Montoro MA, Juanola X, Trujillo-Martin E, Carrillo-Palau M, Matallana V, García-Magallón B, Ber Y, Ramos L, Perez-Pampin E, Ferreiro-Iglesias R, Rodríguez-Alonso L, Marco-Pascual C, Sanz Sanz J; Validación-PIIASER Study Group. Validation of screening criteria for spondyloarthritis in patients with inflammatory bowel disease in routine clinical practice. Dig Liver Dis 2022;54:755-62. [PMID: 35039222 DOI: 10.1016/j.dld.2021.12.010] [Reference Citation Analysis]
|
4 |
Liu D, Saikam V, Skrada KA, Merlin D, Iyer SS. Inflammatory bowel disease biomarkers. Medicinal Research Reviews. [DOI: 10.1002/med.21893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Alsharif IA, Fayed HM, Abdel-Rahman RF, Abd-Elsalam RM, Ogaly HA. Miconazole Mitigates Acetic Acid-Induced Experimental Colitis in Rats: Insight into Inflammation, Oxidative Stress and Keap1/Nrf-2 Signaling Crosstalk. Biology (Basel) 2022;11:303. [PMID: 35205169 DOI: 10.3390/biology11020303] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
6 |
Colquhoun M, Roy A, Kirresh O, Mouyis M. A case of enteropathic arthritis complicated by superimposed bilateral septic arthritis of the hips. Mod Rheumatol Case Rep 2021;5:387-90. [PMID: 33238804 DOI: 10.1080/24725625.2020.1857021] [Reference Citation Analysis]
|
7 |
Zacharia B, Roy A. Ankylosing Spondylitis and Other Seronegative Arthritis. Connective Tissue Disease - Current State of the Art 2020. [DOI: 10.5772/intechopen.82332] [Reference Citation Analysis]
|
8 |
Sood A, Ahuja V, Midha V, Sinha SK, Pai CG, Kedia S, Mehta V, Bopanna S, Abraham P, Banerjee R, Bhatia S, Chakravartty K, Dadhich S, Desai D, Dwivedi M, Goswami B, Kaur K, Khosla R, Kumar A, Mahajan R, Misra SP, Peddi K, Singh SP, Singh A. Colitis and Crohn's Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease. Intest Res 2020;18:355-78. [PMID: 32646198 DOI: 10.5217/ir.2019.09176] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
|
9 |
Finucci A, Ditto MC, Parisi S, Borrelli R, Priora M, Realmuto C, Fusaro E. Rheumatic manifestations in inflammatory bowel disease. Minerva Gastroenterol (Torino) 2021;67:79-90. [PMID: 32623869 DOI: 10.23736/S2724-5985.20.02726-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
10 |
Rowaiye AB, Olubiyi J, Bur D, Uzochukwu IC, Akpa A, Esimone CO. IN SILICO SCREENING AND MOLECULAR DYNAMIC SIMULATION STUDIES OF POTENTIAL SMALL MOLECULE IMMUNOMODULATORS OF THE KIR2DS2 RECEPTOR.. [DOI: 10.1101/2020.05.10.087148] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
11 |
González-lama Y, Sanz J, Bastida G, Campos J, Ferreiro R, Joven B, Gutiérrez A, Juanola X, Sicilia B, Veroz R, Gisbert JP, Chaparro M, Domènech E, Esteve M, Gomollón F. Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritis. Gastroenterología y Hepatología (English Edition) 2020;43:273-283. [DOI: 10.1016/j.gastre.2020.01.003] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
12 |
González-Lama Y, Sanz J, Bastida G, Campos J, Ferreiro R, Joven B, Gutiérrez A, Juanola X, Sicilia B, Veroz R, P Gisbert J, Chaparro M, Domènech E, Esteve M, Gomollón F. Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritis. Gastroenterol Hepatol 2020;43:273-83. [PMID: 32247533 DOI: 10.1016/j.gastrohep.2020.01.005] [Cited by in Crossref: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
13 |
Wang W, Cleveland NK, Ollech J, Rubin DT. Use of Tofacitinib for the Treatment of Arthritis Associated With Ulcerative Colitis. ACG Case Rep J 2019;6:e00226. [PMID: 31750389 DOI: 10.14309/crj.0000000000000226] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
14 |
Nielsen OH, Ainsworth MA, Steenholdt C. Methotrexate for inflammatory bowel disease: time for reconsideration. Expert Rev Gastroenterol Hepatol 2019;13:407-9. [PMID: 30895827 DOI: 10.1080/17474124.2019.1596797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
15 |
Waldron T. Joint Disease. Ortner's Identification of Pathological Conditions in Human Skeletal Remains. Elsevier; 2019. pp. 719-48. [DOI: 10.1016/b978-0-12-809738-0.00020-x] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
16 |
Paramsothy R, Irving P. Extra-intestinal Manifestations in Inflammatory Bowel Disease: Diagnosis and Management. Biomarkers in Inflammatory Bowel Diseases 2019. [DOI: 10.1007/978-3-030-11446-6_15] [Reference Citation Analysis]
|
17 |
Ma C, Ascoytia C, McCarrier KP, Martin M, Feagan BG, Jairath V. Physicians' Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn's Disease. Dig Dis Sci 2018;63:2555-63. [PMID: 29959726 DOI: 10.1007/s10620-018-5181-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
|
18 |
Ma C, Dutton SJ, Cipriano LE, Singh S, Parker CE, Nguyen TM, Guizzetti L, Gregor JC, Chande N, Hindryckx P, Feagan BG, Jairath V. Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease. Aliment Pharmacol Ther 2018;48:114-26. [PMID: 29851091 DOI: 10.1111/apt.14821] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
19 |
. Literatur. ELSEVIER ESSENTIALS Rheumatologie 2018. [DOI: 10.1016/b978-3-437-21401-1.16001-5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
20 |
Ali Y. Questions 81–90. Self Assessment in Rheumatology 2018. [DOI: 10.1007/978-3-319-89393-8_9] [Reference Citation Analysis]
|
21 |
Hablot J, Peyrin-Biroulet L, Kokten T, El Omar R, Netter P, Bastien C, Jouzeau JY, Sokol H, Moulin D. Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice. PLoS One 2017;12:e0184624. [PMID: 28926599 DOI: 10.1371/journal.pone.0184624] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
|
22 |
Zhao Y, Wang J, Liu Z, Lin H, Shi Y, Sun X. Pulmonary dysfunction in 114 patients with inflammatory bowel disease. Medicine (Baltimore) 2017;96:e6808. [PMID: 28471982 DOI: 10.1097/MD.0000000000006808] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
|
23 |
Dai S, Gu H, Lin Q, Xing T, Chen M, Zhong T, Wu G, Feng Y, Liu H, Gao Y, Jian H, Zhang M, Mo H, Zhu H, Chen D, Xu J, Zou Y, Chi H, Zhu Y. Disequilibrium in the CD8(+)CD28(+)/CD8(+)CD28(-) T Lymphocyte Balance Is Related to Prognosis in Rats with Trinitrobenzenesulfonic Acid-Induced Colitis. Dig Dis Sci 2017;62:639-51. [PMID: 28035546 DOI: 10.1007/s10620-016-4424-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
24 |
Chouliaras G, Margoni D, Dimakou K, Fessatou S, Panayiotou I, Roma-Giannikou E. Disease impact on the quality of life of children with inflammatory bowel disease. World J Gastroenterol 2017; 23(6): 1067-1075 [PMID: 28246481 DOI: 10.3748/wjg.v23.i6.1067] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
|
25 |
Tindell A, Johnsson H, Mcinnes IB. Arthritis, Arthropathy, and Osteoporosis in Inflammatory Bowel Disease. Crohn's Disease and Ulcerative Colitis 2017. [DOI: 10.1007/978-3-319-33703-6_55] [Reference Citation Analysis]
|
26 |
González-lama Y, Sanz J, Bastida G, Campos J, Ferreiro R, Joven B, Gutiérrez A, Juanola X, Sicilia B, Veroz R, Gisbert J, Chaparro M, Domènech E, Esteve M, Gomollón F. Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el tratamiento de pacientes con espondiloartritis asociada a enfermedad inflamatoria intestinal. Enfermedad Inflamatoria Intestinal al Día 2017;16:1-14. [DOI: 10.1016/j.eii.2016.09.002] [Reference Citation Analysis]
|
27 |
Peyrin-Biroulet L, Van Assche G, Gómez-Ulloa D, García-Álvarez L, Lara N, Black CM, Kachroo S. Systematic Review of Tumor Necrosis Factor Antagonists in Extraintestinal Manifestations in Inflammatory Bowel Disease. Clin Gastroenterol Hepatol 2017;15:25-36.e27. [PMID: 27392760 DOI: 10.1016/j.cgh.2016.06.025] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 14.0] [Reference Citation Analysis]
|
28 |
Zhang XL, Li YF, Zhou P. Extraintestinal manifestations of inflammatory bowel disease and their treatment strategies. Shijie Huaren Xiaohua Zazhi 2016; 24(6): 894-901 [DOI: 10.11569/wcjd.v24.i6.894] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
29 |
Nanke Y, Kobashigawa T, Yamanaka H, Kotake S. A case of enteropathic arthritis successfully treated with methotrexate. Jpn J Clin Immunol 2016;39:219-222. [DOI: 10.2177/jsci.39.219] [Reference Citation Analysis]
|